Luaran Maternal pada Ibu Hamil dengan Covid-19 di Daerah Istimewa Yogyakarta Studi Kohort Retrospektif
Kartika Wahyuningtyas Utami(1*), Irwan Taufiqur Rachman(2), Detty Siti Nurdiati(3)
(1) Universitas Gadjah Mada
(2) 
(3) 
(*) Corresponding Author
Abstract
Background: Coronavirus is a disease at the end of 2019 caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) which now was declared a pandemic by WHO on March 11, 2020. Indonesia reported the first case of COVID-19 on March 2, 2020 and the number still increase until now. The studies of SARS-CoV-2 infection on pregnancy and maternal outcomes are still uncertain since evidence regarding the disease is still ongoing. Moreover, the pregnant women have a higher risk of morbidity and mortality than the general population.
Objective: This study aimed to determined the relationship among COVID-19 in pregnancy with maternal outcome at Yogyakarta
Methods: This is a retrospective cohort study. The subjects were pregnant women who were diagnosed confirm COVID-19. The research subjects were taken at Dr. Sardjito Hospital and Akademik UGM Hospital from March 2020 to August 2021.
Results and Discussion: Among all 436 research subjects, obtained 340 sampels that met the criteria for analysis. The characteristics of subjects showed patients with aged >35 years (58.24%), and gestational age ≥37 weeks (79.41%). There were correlated significantly between confirmed symptomatic COVID-19 in pregnant women with prematurity (RR 2,42, CI 95% 1,44–4.04), requiring ICU (RR 53.89, CI 95% 3.33–870.45), length of stay (RR 1.97, CI 95% 1,05–3,68), and maternal mortality maternal (RR 38.08, CI 95% 2,34–619,83) compared with asymptomatic COVID-19. There was no correlated significantly (p>0.05) between COVID-19 in pregnancy with mode of delivery. Age, obesity, hypertension and diabetes mellitus have no correlated significantly with maternal outcomes
Conclusion: Pregnancy as an independent risk factor for symptomatic COVID-19 that is likely independent of other comorbidities. Pregnant women who symptomatic COVID-19 increase the risk of worse maternal outcome compare with asymptomatic COVID-19. The mode of delivery decided based on medical and obstetric indication.
Keywords : COVID-19; pregnancy; co-morbidities; maternal outcomes
Keywords
References
- Aziz MA, Chalid MT, Saroyo YB, Budayasa R, Irwinda R, Akbar MIA. Rekomendasi Penanganan Virus Corona (COVID-19) Pada Maternal (Hamil, Bersalin, dan Nifas) [Internet]. JKT (Indonesia): POGI; c2020 [cited ]. Available from: https://pogi.or.id/publish/wpcontent/uploads/2020/10/Rekomendasi-COVID-Maternal-POGI.pdf.
- Ardian M, Laksana C, Habibie PH, Wardhana MP, Erza K. Situation report: maternal health management during COVID-19 pandemic at soetomo general hospital and universitas airlangga academic hospital, surabaya indonesia. Sys Rev Pharm. 2020;11:467–71
- Breslin N, Baptiste C, Gyamfi-Bannerman C, et al. Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women: Two weeks of confirmed presentations to an affiliated pair of New York City hospitals. Am J Obstet Gynecol MFM 2020;2:100118.
- Chen, Yanfen, & Bai, J. (2020). Maternal and infant outcomes of full-term pregnancy combined with COVID-2019 in Wuhan, China: retrospective case series. Archives of Gynecology and Obstetrics, 1–7. https://doi.org/10.1007/s00404-020-05573-8
- Docherty AB, Harrison EM, Green CA, et al, ISARIC4C investigators. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ 2020;369:m1985. doi:10.1136/ bmj.m1985
- Gennaro, F. Di, Pizzol, D., Marotta, C., Antunes, M., Racalbuto, V., Veronese, N., & Smith, L. (2020). Coronavirus Diseases ( COVID-19 ) Current Status and Future Perspectives : A Narrative Review. International Journal of Environmental Research and Public HealthEnvironmental Research and Public Health, 17(2690), 1–11. https://doi.org/10.3390/ijerph170 82690
- Jose Villar,MD, Shabina Ariff MD, Robert B.Gunier,PhD et al. Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 InfectionThe INTERCOVID Multinational Cohort Study. JAMA Pediatr. 2021;175(8):817-826. doi:10.1001/jamapediatrics.2021.1050
- Lingeswaran, M., Goyal, T., Ghosh, R., & Suri, S. (2020). Inflammation , Immunity and Immunogenetics in COVID-19 : A Narrative Review. Indian Journal of Clinical Biochemistry, 35(3), 260–273. https://doi.org/10.1007/s12291- 020-00897-3
- Manon Vouga, Guillaume Favre1, Oscar Martinez‐Perez,. et al., Maternal outcomes and risk factors for COVID‐19 severity among pregnant women. . Nature portofolio 2021. https://doi.org/10.1038/s41598-021-92357-y
- Megan CO, Annessa SK, Ebony B.Carter, et al. Pregnancy as a risk factor for severe coronavirus disease 2019 using standardized clinical criteria. Am J Obstet Gynecol MFM. 2021 May; 3(3): 100319
- Metz TD, Clifton RG, Hughes BL, Sandoval GJ, Grobman WA, Saade GR, et al. Association of SARS-CoV-2 Infection With Serious Maternal Morbidity and Mortality From Obstetric Complications. JAMA. 2022 Feb 22;327(8):748–59. doi: 10.1001/jama.2022.1190
- Mor G, Aldo P, Alvero A. The unique immunological and microbial aspects of pregnancy. Nature Rev Immunol. 2017;17(8):469-82. https://doi.org/10.1038/nri.2017.64
- Polónia-Valente, R., Moucho, M., Tavares, M., Vilan, A., Montenegro, N., & Rodrigues, T. (2020). Vaginal delivery in a woman infected with SARS-CoV-2 - The first case reported in Portugal. European journal of obstetrics, gynecology, and reproductive biology, 250, 253–254
- Rangchaikul, P., and Venketaraman, V. (2021). SARS-CoV-2 and the immune response in pregnancy with delta variant considerations. Infect Dis. Rep. 13, 993–1008. https://doi.org/10.3390/idr13040091
- Rees EM, Nightingale ES, Jafari Y, Waterlow NR, Clifford S, Pearson CA, et al. COVID-19 length of hospital stay: a systematic review and data synthesis. Medrxiv. 2020:1-30
- RCOG (2020) ‘Coronavirus ( COVID-19 ) Infection in Pregnancy’, (June).
- Society for Maternal Fetal Medicine. Management Considerations for Pregnant Patients With COVID-19 February 2, 2021; updated from earlier versions on January 7, 2021 and July 2, June 16; and April 30, 2020)
- UKOSS MBRRACE Infographic v13, 2021, UKOSSInfographic MBRRACE UK Rapid COVID-19 DEC 2021 Infographic v13.Pdf (ox.ac.uk).https://www.npeu.ox.ac.uk/assets/downloads/npeu-news/MBRRACE UK Rapid COVID-19 DEC 2021 Infographic v13.pdf.
- Vousden, N., Bunch, K., Morris, E., Simpson, N., Gale, C., O’Brien, P., etal. The incidence, characteristics and outcomes of pregnant women hospitalized with symptomatic and asymptomatic SARS-CoV-2 infection in the UK from March to September 2020: a national cohort study using the UK Obstetric Surveillance System (UKOSS). PLoS One 2021;16(5):e0251123
- Valente P, Iarossi G, Federici M, Petroni S, Palma P, Cotugno N, et al. Ocular manifestations and viral shedding in tears of pediatric patients with coronavirus disease 2019: a preliminary report. J Am Assoc Pediatr Ophthalmol Strabismus. 2020. 10.1016/j.jaapos.2020.05.002.
- Zaigham M, Andersson O. Maternal and perinatal outcomes with COVID-19: a systematic review of 108 pregnancies. Acta Obstet Gynecol Scand. 2020;99:823–9
DOI: https://doi.org/10.22146/jkr.77933
Article Metrics
Abstract views : 1272Refbacks
- There are currently no refbacks.
Copyright (c) 2023 The Author(s)
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
SEKRETARIAT JURNAL KESEHATAN REPRODUKSI
Departemen Obstetri dan Ginekologi, FK-KMK, UGM/RS Dr. Sardjito
Jl. Kesehatan No. 1, Sekip Utara, Yogyakarta 55281
Tlp: (0274) 511329 / Faks: (0274) 544003
Email: jurnal.kesehatanreproduksi@ugm.ac.id
Cp: Dwi Astuti +6281802698043